University of Wisconsin, Madison
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Madison sits in the top decile of US sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count).
University of Wisconsin, Madison: 1,039 sponsored US clinical trials, 151 recruiting.
University of Wisconsin, Madison sponsors 1,039 registered US clinical trials on ClinicalTrials.gov, 151 of them currently recruiting, and 712 completed. 98 of these trials are in Phase 3-4 (later-stage) and 251 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 10 trials.
Top-decile sponsor footprint
University of Wisconsin, Madison ranks in the top decile of sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
712 of 824 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,039 total, page 16 of 21
Combination of Magnesium and Lidocaine for the Pretreatment of Pain That is Caused by the Injection of Propofol
NCT01342510
Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)
NCT01354613
Mindfulness Training for Smokers Online Feasibility Study
NCT02164656
MC-5A for Chemotherapy Induced Peripheral Neuropathy
NCT01261780
"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"
NCT01317329
Merck IISP Stewardship Grant for Antibiotic Best Practices
NCT01573195
Resveratrol With or Without Piperine to Enhance Plasma Levels of Resveratrol
NCT01324089
Study Two on the Effectiveness of Mindfulness Training for Smokers
NCT01299909
Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma
NCT01281917
Efficacy of Lanthanum Carbonate in Calciphylaxis
NCT01289626
A Pilot Study to Evaluate a Telepharmacy Intervention to Improve Inhaler Adherence in Veterans With COPD
NCT01270594
Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer
NCT01263613
Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children
NCT01166945
BTX-A Treatment for Palmar Hyperhidrosis
NCT01262339
Atomic Magnetometer for Fetal Biomagnetism
NCT03057665
Attenuation of Pain in Men and Women
NCT01220414
Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?
NCT01166958
Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women
NCT01219595
Effects of Environmental Opportunities and Barriers on Physical Activity, Fitness, and Health in Hispanic Children in Wisconsin
NCT01180972
Topical Lidocaine for Pain Control With Intrauterine Device (IUD) Insertion
NCT01445756
Does Gender Play a Role in Bone-mineral Density Measurement Precision?
NCT01324713
Identifying Treatments to Motivate Smokers to Quit
NCT01122238
The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery
NCT01164644
Evaluation of Treatments to Improve Smoking Cessation Medication Adherence
NCT01120704
Identifying Optimal Smoking Cessation Intervention Components (Cessation)
NCT01116986
Evaluation of the Reproducibility of Jumping Mechanography
NCT01164670
Dysmenorrhea in Women With Crohn's Disease and Ulcerative Colitis
NCT02274714
Moderating the Negative Impact of Abnormal Screening Mammograms
NCT01153126
Trial of Panitumumab/Cisplatin/Fluorouracil Combined With Radiation in Esophageal Cancer
NCT01128387
Study of Panobinostat in Patients With Neuroendocrine Tumors
NCT00985946
Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
NCT01087905
Treatment of Vitamin D Insufficiency
NCT00933244
ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancer
NCT01119118
Trial on the Effectiveness of Mindfulness Training for Smokers
NCT01093599
Safety of Phenylephrine for Oral Mucositis Prevention
NCT01092975
Menominee Stop Tobacco Abuse Renew Tradition Study
NCT01083654
Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications
NCT01039493
Family-Centered Rounds Checklist Implementation
NCT02625142
Interactive Cancer Communication System (ICCS) Directed Physical Activity Enhancement for Colon Cancer Survivors
NCT01133132
Trial of LBH589 in Metastatic Thyroid Cancer
NCT01013597
A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE)
NCT01112995
Estrogen for Triple Negative Breast Cancer
NCT01083641
Feasibility Study: Comparison of Performance Status With Objective Physical Activity Monitors
NCT01063400
Comparison of Videoconference and Face-to-Face Delivery of Cognitive Processing Therapy for Posttraumatic Stress Disorder
NCT00941629
The Effects of Well-being Interventions on Affect, Attention, Sleep, Social Stress and Pain Regulation
NCT01057368
Effectiveness of the CHESS eHealth Cancer Support Intervention in Population-based Care
NCT01033162
Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer
NCT01012401
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
NCT00974233
Air-Q Intubating Laryngeal Airway Versus the Laryngeal Mask Airway (LMA)-Proseal
NCT01328405
The Impact of Educational Materials on Family Behavior
NCT00993434
What is open in the University of Wisconsin, Madison pipeline
151 recruiting of 1,039 indexed (15% open); 712 completed (69%).
Phase mix: 98 late (III/IV) vs 251 early (I/II) (early-phase heavy).
Top condition: Healthy (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Wisconsin, Madison: open-pipeline peers nationwide
Peers matched on 1,039 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,039 trials (± recruiting share)
- University of Washington · 1,048 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Masonic Cancer Center, University of Minnesota · 14% recruiting · 249 trials
- ModernaTX · 14% recruiting · 90 trials
- United States Naval Medical Center, San Diego · 15% recruiting · 41 trials
- The Cleveland Clinic · 14% recruiting · 688 trials
Related
What to do with this University of Wisconsin, Madison page
1,039 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Madison or any single study.
- 151 of University of Wisconsin, Madison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of Wisconsin, Madison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Wisconsin, Madison pipeline card: 1,039 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.